Easton Pharmaceuticals Inc. and its JV partner, BMV Medica SA de CV, announced product delivery and launch of its licensed AmnioSense (AL-Sense) product from its previously announced Gedeon Richter distribution agreement for Mexico. Easton/BMV is also expecting delivery initial Purchase Order for Central America with exclusive Distribution Partner, Windsor Pharmaceuticals, with launch in initial countries in Central America by February, 2018. Products Overview: VS-Sense (VagiSense): is the current brand name of the BV (Bacterial Vaginosis) patented diagnostic test, planned for launch in Mexico and other larger markets in Latin America, but may be renamed depending on the outcome of partner discussions with multi-national pharmaceutical companies, initiated in late 2015 and early 2016.

VagiSense (VS-Sense) is the same product Bayer Pharmaceuticals had licensed and launched in late 2015 in Europe under its brand, Canestest, and with Prestige Distribution currently selling in the US under its brand, Monistat, with multi-million dollars in sales and growing. AL-Sense (AmnioSense): patented amniotic fluid leak test now marketed in two presentations to capture maximum market, and is a unique Point-of-Care diagnostic panty liner for women in late-stage pregnancy able to distinguish between urine and amniotic fluid (breaking of water).